Sage Journals: Discover world-class research

Abstract

Spanish

French

OBJECTIVE:

To report a case of successful desensitization to dapsone for Pneumocystis carinii pneumonia (PCP) prophylaxis in a patient unable to tolerate trimethoprim/sulfamethoxazole (TMP/SMX) desensitization or dapsone at standard doses.

CASE SUMMARY:

A 37-year-old HIV-positive African-American man was treated for pneumonia with TMP/SMX and then continued on the drug for PCP prophylaxis. After experiencing a pruritic maculopapular rash with TMP/SMX, both at standard doses and after attempting a desensitization regimen to the drug, he was started on dapsone for PCP prophylaxis. He experienced a rash and fever after taking dapsone at standard PCP prophylactic doses. At this time, an 18-day oral dapsone rechallenge by dose escalation was attempted, and it was well tolerated.

CONCLUSIONS:

This case suggests that utilization of a dapsone desensitization regimen may permit a viable treatment option in patients previously thought to be intolerant to the agent. More regimens of this type should be attempted and the results published, using both dapsone and TMP/SMX, so that standard desensitization treatment guidelines may eventually be adopted.

Keywords

dapsone trimethoprim/sulfamethoxazole hypersensitivity desensitization

Get full access to this article

View all access options for this article.

References

Weinberger

. Recent advances in pulmonary medicine. N Engl J Med 1993;328: 1462–70.

Graham

NMH

Zeger

Park

Vermund

Detels

Rinaldo

The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 1992;326:1037–42.

Gallant

Moore

Chaisson

. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 1994;120: 932–44.

White

Haddad

Brunner

Sainz

. Desensitization to trimethoprim-sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia. Ann Allergy 1989;62: 177–9.

Prussick

Shear

. Dapsone hypersensitivity syndrome. J Am Acad Dermatol 1996;35: 346–9.

Tomecki

Catalano

. Dapsone hypersensitivity: The sulfone syndrome revisited. Arch Dermatol 1981;117: 38–9.

Chalasani

Baffoe-Bonnie

Jurado

. Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. South Med J 1994;87: 1145–6.

Johnson

Cattau

Kuritsky

Zimmerman

. Liver involvement in the sulfone syndrome. Arch Intern Med 1986;146: 875–7.

Carr

Penny

Cooper

. Efficacy and safety of rechallenge with low-dose trimethoprim-sulfamethoxazole in previously hypersensitive HIV-infected patients. AIDS 1993;7: 65–71.

10.

Koopmans

van der Ven

AJAM

Vree

van der Meer

JWM

. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: Allergic or toxic? AIDS 1995;9: 217–22.

11.

Centers for Disease Control and Prevention. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV. MMWR Morb Mortal Wkly Rep 1992;41:1–11.

12.

Everson-Mays

Weidle

. Restarting trimethoprim-sulfamethoxazole after a hypersensitivity reaction in patients infected with the human immunodeficiency virus. Am J Health Syst Pharm 1997;54: 1545–50.

13.

Carr

. Role of desensitization for drug hypersensitivity in patients with HIV infection. Drug Saf 1997;17: 119–26.

14.

O'Kane

Schneeweiss

. Trimethoprim-sulfamethoxazole-induced sepsis-like syndrome in a patient with AIDS. JABFP 1996;9: 448–50.

15.

Belchi-Hernandez

Espinosa-Parra

. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol 1996;76: 355–8.

16.

Hardy

. Treatment and prevention of PCP and multiple opportunistic pathogen prophylaxis strategies. Improving the management of HIV disease: a publication of the International AIDS Society — USA 1995;3: 20–4.

17.

Metroka

Lewis

Jacobus

. Desensitization to dapsone in HIV-positive patients (letter). JAMA 1992;267:512.

18.

Beumont

Graziani

Ubel

MacGregor

. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus—infected patients with allergy to trimethoprim/sulfamethoxazole. Am J Med 1996;100: 611–6.

Successful Desensitization to Dapsone for Pneumocystis Carinii Prophylaxis in an HIV-Positive Patient